Epstein Secrets

19, promoting a secretive solution with no published scientific evidence he claims will conquer the new coronavirus." On Sunday in a TV appearance, Maduro touted "a powerful antiviral, very powerful, that neutralizes EFTA00148113 the coronavirus." The AP adds, "The local National Academy of Medicine

izes EFTA00148113 the coronavirus." The AP adds, "The local National Academy of Medicine said it appeared be derived from the common herb thyme." Maduro called the treatment "carvativir" and said that it "has been under testing for nine months among Venezuelans ill with the coronavirus." NYTimes Ana

ons given the complications and slower-than-hoped rollout of authorized vaccines" from Pfizer and Moderna. The Wall Street Journal (1/26, Grossman, Loftus, Subscription Publication, 8.41M) reports J&J discussed its vaccine plans Tuesday as it reported fourth-quarter earnings. Eli Lilly Reports Positiv

y the country's military, has begun retail operations in Venezuela, according to officials and records detailing the move. Ekta is working with the Maduro government's emergency food program. Pearl's Killers Could Soon Be Free. The CBS Weekend NewsVi (7/5, story 6, 1:50, Garrett, 2.32M) reported that

ed forward as top candidates to fight" the pandemic. Vaccine Developers Compete For Healthy Volunteers. The Wall Street Journal (7/5, Al, Hopkins, Loftus, Subscription Publication, 7.57M) reports vaccine developers are competing to recruit the thousands of healthy volunteers needed for testing, taking

and said it was in discussions with the roughly 60 countries that have backed Guaido and they would stick with him." They withdrew recognition "for Maduro after his 2018 re-election, which they regarded as a sham." Abrams "said US deportations of Venezuelans have halted but court decisions have led to

coronavirus infections." The Times adds that Novavax "has never brought a vaccine to market in its 33-year history." The Wall Street Journal (8/4, Loftus, Subscription Publication, 7.57M) also covers the results. NIH, Eli Lilly Seeking Volunteers For Antibody Drug Trials. On NBC Nightly NewsVi (8/4,